ADRB3 and Obesity: Ensuing DNA methylation of the promoter leads to diminished Adrb3 expression and blockade of thermogenesis and lipolysis or beiging, which in turn facilitates obesity and associated pathological states such as insulin resistance and dyslipidemia.